Barrett’s oESophagus Trial 3 (BEST3): Cluster randomised controlled trial comparing the CytospongePTMP-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care

1st January 2018 - ongoing

Status: Active

Specialism: Imaging, Advanced Endoscopic Imaging, Upper GI, Barrett's Oesophagus.

Team:

Publications
Title
Grants
Title Amount